CN105920276A - Topical combined medicament for treating long-lasting wound - Google Patents
Topical combined medicament for treating long-lasting wound Download PDFInfo
- Publication number
- CN105920276A CN105920276A CN201610220643.6A CN201610220643A CN105920276A CN 105920276 A CN105920276 A CN 105920276A CN 201610220643 A CN201610220643 A CN 201610220643A CN 105920276 A CN105920276 A CN 105920276A
- Authority
- CN
- China
- Prior art keywords
- gram
- tinea ranae
- grams
- active ingredient
- plumbum preparatium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a topical combined medicament for treating long-lasting wound. The topical combined medicament comprises topical ointment, tadpole toxin-relieving powder and tissue regeneration powder. The topical ointment comprises active ingredients of sesame oil, frankincense, myrrh, dragon's blood, keel, safflower, radices trichosanthis, Chinese angelica, pangolin scales, human hair and yellow lead. The tadpole toxin-relieving powder comprises active ingredients of gypsum rubrum, mirabilite, Rheum palmatum L., and live tadpoles. The tissue regeneration powder comprises active ingredients of frankincense, myrrh, pearl catechu, mountain tallow, fossil fragments, corium elephatis, dragon's blood and borneol. The traditional Chinese medicine topical combined medicament has the advantages of convenient use, short course of treatment, low cost, quick effectiveness and high cure rate.
Description
Technical field
The present invention relates to a kind of topical compositions medicament treating obstinate wound, it is applicable to treat what diabetes caused
Non-healing wounds, various wound obstinates, pimple (tuberculosis), the external of innominate toxic swelling (inflammation).
Background technology
At present, the various non-healing wounds that treatment diabetes cause, wound obstinate, the wound that innominate toxic swelling causes is not
The medicine of healing, although a lot, but, these medicines or pharmaceutical preparation all there are many shortcoming and defect, and therapeutic effect is all paid no attention to
Thinking, oral medicine or injection medicament, side effect is relatively big, and some courses for the treatment of are long, and curative effect is slow, and cure rate is low, and the table of controlling having does not effects a permanent cure, and has
Although medicine can control wound, but owing to medicine is without life function, can not heal, and easily cause suppurating sore, very
Permanent the most cause amputation to have, to death, and the medicament of prior art mostly is antibiotics, side effect big and
Treatment cost is high mostly, wound healing effect is undesirable.
Summary of the invention
It is an object of the invention to overcome the deficiencies in the prior art, it is provided that a kind of easy to use, short treating period, good effect, no
Amputation, instant effect, cure rate height and the topical compositions medicament treating obstinate wound having no side effect.
The purpose of the present invention can be realized by following technical measures:
A kind of topical compositions medicament treating obstinate wound, it is characterised in that: topical compositions medicament contains external plaster
Medicine, Tinea Ranae Herba Sidae Szechuensis and SHENGJISAN;
Described externally applied ointment, it makes active ingredient and is: 500-1000 gram of Oleum Sesami, each 0.3-1 of Olibanum, Myrrha, Sanguis Draxonis
Gram, Os Draconis (fire is forged) 1-3 gram, Flos Carthami, Radix Trichosanthis, Radix Angelicae Sinensis, each 0.5-1 gram of river Squama Manis, Crinis Carbonisatus 1-3 gram, Plumbum preparatium, externally applied ointment
Manufacture method is for first to put in pot by Oleum Sesami, then is immersed in Oleum Sesami in above-mentioned whole medicines in addition to Plumbum preparatium addition oil cauldron,
Then boil with fire, be brewed into until the Oleum Sesami in oil cauldron and Oleum Sesami is instilled in water after beading, (described beading refers to drip Oleum Sesami
After after entering in water, Oleum Sesami is pearl and stirring water, oil droplet does not dissipates, i.e. Oleum Sesami be provided with certain viscosity oil will not in pearl
Scatter), in filtering pot, medicinal residues take out, and after taking out medicinal residues weigh remaining oil, and oil compares with Plumbum preparatium 1 according to oil after weighing
The weight ratio of 1.5-2.5, in oil under enter Plumbum preparatium, under enter Plumbum preparatium after oil and the homogeneous mixture of Plumbum preparatium are made externally applied ointment;
Described Tinea Ranae Herba Sidae Szechuensis, it makes active ingredient and is: Mirabilitum crystallina 5-10 gram, clean Mirabilitum 4-8 gram, Radix Et Rhizoma Rhei 6-12
Gram, live Tinea Ranae 500-2000 gram, and it is the Tinea Ranae that lives that Tinea Ranae alive described here refers to during feeding, and the Tinea Ranae that then will live is again by following
Processing after just become the raw material being used as medicine.The manufacture method of Tinea Ranae Herba Sidae Szechuensis is first Mirabilitum crystallina, clean Mirabilitum and Radix Et Rhizoma Rhei to be mixed
After be ground into fine flour, then take Ha Noi and become to live greatly that (Rana nigromaculata becomes Tinea Ranae in water to Tinea Ranae after laying eggs, then changing in quality into little green grass or young crops end to end
The frog, Tinea Ranae alive described here refers to that ovum becomes the Tinea Ranae of major part long-tail) drag in closed cans, after in work Tinea Ranae closed cans, use mud
Sealed cans mouth, then the tank of mudding tank mouth is buried to earth 100-200 days, the degree of depth burying tank in soil is generally 20-50 centimetre, treats
Becoming Tinea Ranae water after Tinea Ranae alive chemical conversion water in tank, this is a corruption process of Tinea Ranae, then takes Tinea Ranae water 100-200 milliliter and put
Enter in bowl, dry in the shade after bowl adding above-mentioned fine flour 50-100 gram and stirring, then the solid abrasive after drying in the shade is the most also
Become fine flour, be Tinea Ranae Herba Sidae Szechuensis;
Described SHENGJISAN, it makes active ingredient and is: Olibanum, Myrrha, each 1-2 gram of Margarita, catechu, Halloysitum Rubrum, Os Draconis, as
Skin, Sanguis Draxonis 10-20 gram, 2-4 gram of mix homogeneously of Borneolum Syntheticum is processed into fine flour, is SHENGJISAN.
The purpose of the present invention can also be realized by following technical measures:
Externally applied ointment of the present invention, it makes active ingredient and is: 600-900 gram of Oleum Sesami, Olibanum, Myrrha, Sanguis Draxonis are each
0.5-0.8 gram, Os Draconis (fire is forged) 1.5-2.5 gram, Flos Carthami, Radix Trichosanthis, Radix Angelicae Sinensis, each 0.7-0.9 gram of river Squama Manis, Crinis Carbonisatus 1.5-2.5
Gram, Plumbum preparatium, taking out the weight ratio of oil and Plumbum preparatium after medicinal residues is 1 to compare 1.6-2.2;
Described Tinea Ranae Herba Sidae Szechuensis, it makes active ingredient and is: Mirabilitum crystallina 7-9 gram, clean Mirabilitum 5-7 gram, Radix Et Rhizoma Rhei 8-10
Gram, live Tinea Ranae 700-1500 gram;
Described SHENGJISAN, it makes active ingredient and is: Olibanum, Myrrha, each 1.2-1.8 gram of Margarita, catechu, Halloysitum Rubrum, dragon
Bone, Corium elephatis, Sanguis Draxonis 12-18 gram, Borneolum Syntheticum 2.5-3.5 gram.
Externally applied ointment of the present invention, it makes active ingredient and is: 800 grams of Oleum Sesami, Olibanum, Myrrha, Sanguis Draxonis each 0.7
Gram, Os Draconis (fire is forged) 2 grams, each 0.8 gram of Flos Carthami, Radix Trichosanthis, Radix Angelicae Sinensis, river Squama Manis, Crinis Carbonisatus 2 grams, Plumbum preparatium, after taking out medicinal residues, oil is with yellow
Red weight ratio is 1 to 2;
Described Tinea Ranae Herba Sidae Szechuensis, it makes active ingredient and is: Mirabilitum crystallina 8 grams, clean Mirabilitum 6 grams, Radix Et Rhizoma Rhei 9 grams, live Ke
Tadpole 1000 grams;
Described SHENGJISAN, it makes active ingredient and is: Olibanum, Myrrha, each 1.5 grams of Margarita, catechu, Halloysitum Rubrum, Os Draconis, as
Skin, Sanguis Draxonis 15 grams, Borneolum Syntheticum 3 grams.
Above-mentioned each crude drug all can amplify in proportion, to adapt to small lot batch manufacture.
Using method of the present invention is: determine the size of cream medicinal cloth with wound size, is spread out on cloth by externally applied ointment, will wound
After mouth cleaning and sterilizing, early stage is rear in being first sprinkling upon wound (coming to a head or rotten position of wound) with Tinea Ranae Herba Sidae Szechuensis (can also be adjusted with water
Muddled affected part), it is stained with externally applied ointment and spends two days and change a medicine, repeat to change through above-mentioned 1-3 time (dressing change frequency is depending on the state of an illness)
After medicine has pulled out poison, i.e. wound come to a head or rotten position is not suppurated to outside water in spilling property, produce healing or the sign of long new meat,
It is stained with externally applied ointment in being sprinkling upon wound by SHENGJISAN again, crosses and change once for two days, then (dressing change frequency is regarding the state of an illness through above-mentioned 1-3 time
Depending on) after the granulation promoting that repeats to change dressings, put down to wound pus stream complete wound length, till wound healing.
The present invention compared with prior art, has the advantage that
1, the present invention uses composite reagent, by table to inner, takes stopgap measures and effects a permanent cure, externally applied ointment blood circulation promoting and blood stasis dispelling, sterilization removing toxic substances;Tinea Ranae
Herba Sidae Szechuensis is deeply drawn out pus by applying a plaster to the affected part, and this dissipates can control unknown big poison, and all fire-toxin, the curative effect that pestilent toxicity applies is obvious;SHENGJISAN deeper into disease at, row
Poison life, promotes wound healing.
2, composite reagent wound curative effect of the present invention is fast, and cure rate is high, has no side effect, not only Zhi Biao but also effect a permanent cure, easy to use,
The advantage that treatment cost is low.The function of the present invention: blood circulation promoting and blood stasis dispelling, toxin expelling, hard masses softening and resolving, clearing away heat and discharging pus, effect of granulation promoting.
3, the present invention treats pimple (tuberculosis), and plaster, according to tuberculosis size, is spread out on cloth, is bonded at by innominate toxic swelling (inflammation)
In tuberculosis, early stage is shapeless, and by blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, tuberculosis spontaneous recovery, the later stage comes to a head, have mouth to rule by law in order to top again
Treat.
4, the present invention treats innominate toxic swelling (inflammation) according to inflammation size, is spread out on cloth by plaster, is stained with three and changes once,
Cure for two to three times.
Clinical trial shows: the present invention hinders through treatment non-healing wounds, innominate toxic swelling, 300 many cases, clinical trial certificate
Mouth cure rate 65%, effective percentage 95%, inefficiency 5%, without any side effects;Pimple cure rate 60% effective percentage 85%, nothing
Efficiency 15%, without any side effects, innominate toxic swelling cure rate 80%, effective percentage 90%, inefficiency 10%, make without any poison is secondary
With.
The several model cases that utilize the present invention treat are set forth below:
1, king so-and-so, man, 48 years old now, Handan in Hebei province office working, within 2010, suffer from diabetic foot, five toes swell
Swollen suppuration, sole front toe all suppurates to heel, and after certain county hospital is performed an operation, the deep 3cm of wound, long toe, can to heel
See foot internal ligament, through in hospitalize disunion in March, through with after this medicine, wound toxin expelling, detumescence, start after three medications to rise
Level, healing, and long good after no recurrence.
2, Lin, man, 60 years old, Daming County, Handan, Hebei province town people from village, suffers from heel in 2008 and damages, through hospital
Treatment, wound meeting pus, meat rots to expose bone, sees ligament, wound width 6cm, long 15cm, controls a month wound not in hospital
More, with after this medicine, start toxin expelling, detumescence, start granulation promoting, three medication wound healings, do not recur again.
3, Yan so-and-so, female, 75 years old now, Handan in Hebei province retired cadre, within 1992, suffer from lymphoid tuberculosis, control through hospital
Treating, tuberculosis loses detumescence and increases on the contrary, with this medicine once after tuberculosis detumescence, after medication three times, tuberculosis disappears, and does not forever recur.
Detailed description of the invention
5 detailed description of the invention of the present invention, the drug component in each embodiment is enumerated below by the mode of list
All to be buied by market, the Tinea Ranae that lives be Oviductus Ranae seed just under time Ha Noi have Tinea Ranae to become to drag for end to end in closed cans greatly, Crinis Carbonisatus is for getting a haircut
The hair that shop is collected.Topical compositions medicament contains externally applied ointment, Tinea Ranae Herba Sidae Szechuensis and SHENGJISAN;
Described externally applied ointment, it makes active ingredient and is: 500-1000 gram of Oleum Sesami, each 0.3-1 of Olibanum, Myrrha, Sanguis Draxonis
Gram, Os Draconis (fire is forged) 1-3 gram, Flos Carthami, Radix Trichosanthis, Radix Angelicae Sinensis, each 0.5-1 gram of river Squama Manis, Crinis Carbonisatus 1-3 gram, Plumbum preparatium, externally applied ointment
Manufacture method is for first to put in pot by Oleum Sesami, then is immersed in Oleum Sesami in above-mentioned whole medicines in addition to Plumbum preparatium addition oil cauldron,
Then boiling with fire, be brewed into until the Oleum Sesami in oil cauldron and instill in water after beading by one-tenth Oleum Sesami, in filtering pot, medicinal residues take out,
Take out after medicinal residues and remaining oil weighed, oil weigh after according to weight ratio than 1.5-2.5 of oil and Plumbum preparatium 1, in oil under enter Huang
Pellet, under enter Plumbum preparatium after oil and the homogeneous mixture of Plumbum preparatium are made externally applied ointment;
Described Tinea Ranae Herba Sidae Szechuensis, it makes active ingredient and is: Mirabilitum crystallina 5-10 gram, clean Mirabilitum 4-8 gram, Radix Et Rhizoma Rhei 6-12
Gram, live Tinea Ranae 500-2000 gram, and the manufacture method of Tinea Ranae Herba Sidae Szechuensis is for being ground into after first Mirabilitum crystallina, clean Mirabilitum and Radix Et Rhizoma Rhei being mixed
Fine flour, then take Ha Noi and become the Tinea Ranae that lives end to end greatly to drag in closed cans, in Tinea Ranae closed cans of living after employing mudding tank mouth, then by mudding
The tank of tank mouth buries to earth 100-200 days, becomes Tinea Ranae water, then take Tinea Ranae water 100-after the Tinea Ranae alive in tank is melted into water
Put in bowl for 200 milliliters, bowl add above-mentioned fine flour 50-100 gram and dries in the shade, then the solid after drying in the shade grinds well and closes in tank,
It is Tinea Ranae Herba Sidae Szechuensis;
Described SHENGJISAN, it makes active ingredient and is: Olibanum, Myrrha, each 1-2 gram of Margarita, catechu, Halloysitum Rubrum, Os Draconis, as
Skin, Sanguis Draxonis 10-20 gram, 2-4 gram of mix homogeneously of Borneolum Syntheticum is processed into fine flour, is SHENGJISAN.
Externally applied ointment embodiment unit: gram
Note: the consumption of Plumbum preparatium in above-mentioned 5 embodiments, respectively being oily and Plumbum preparatium weight ratio after taking out medicinal residues is 1
Ratio 1.6,1 to 2.2,1 to 1.8,1,2,1 to 1.9.
Tinea Ranae Herba Sidae Szechuensis embodiment unit: gram
Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | |
Mirabilitum crystallina | 6 | 5 | 8 | 10 | 7 |
Clean Mirabilitum 4-8 | 5 | 8 | 6 | 7 | 4 |
Os Draconis | 1.5 | 1.8 | 2 | 2.2 | 2.5 |
Radix Et Rhizoma Rhei 6-12 | 12 | 6 | 10 | 8 | 10 |
Note: the consumption of the Tinea Ranae that lives in above-mentioned 5 embodiments, is and becomes Tinea Ranae water after the Tinea Ranae alive in tank is melted into water,
Take Tinea Ranae water and be no less than 100 milliliters, in Tinea Ranae water, add the whole medicaments in the various embodiments described above respectively.
SHENGJISAN embodiment unit: gram
Claims (3)
1. the topical compositions medicament treating obstinate wound, it is characterised in that: topical compositions medicament contain externally applied ointment,
Tinea Ranae Herba Sidae Szechuensis and SHENGJISAN;
Described externally applied ointment, it makes active ingredient and is: 500-1000 gram of Oleum Sesami, each 0.3-1 gram of Olibanum, Myrrha, Sanguis Draxonis, dragon
1-3 gram of bone (fire is forged), Flos Carthami, Radix Trichosanthis, Radix Angelicae Sinensis, each 0.5-1 gram of river Squama Manis, Crinis Carbonisatus 1-3 gram, Plumbum preparatium, the making of externally applied ointment
Method is for first to put in pot by Oleum Sesami, then is immersed in Oleum Sesami, then in above-mentioned whole medicines in addition to Plumbum preparatium addition oil cauldron
Boiling with fire, be brewed into until the Oleum Sesami in oil cauldron and instill in water after beading by Oleum Sesami, in filtering pot, medicinal residues take out, and take out medicine
After slag, remaining oil is weighed, oil weigh after according to weight ratio than 1.5-2.5 of oil and Plumbum preparatium 1, in oil under enter Plumbum preparatium, under enter
After Plumbum preparatium, the homogeneous mixture of oil with Plumbum preparatium is made externally applied ointment;
Described Tinea Ranae Herba Sidae Szechuensis, it makes active ingredient and is: Mirabilitum crystallina 5-10 gram, clean Mirabilitum 4-8 gram, Radix Et Rhizoma Rhei 6-12 gram,
Live Tinea Ranae 500-2000 gram, and the manufacture method of Tinea Ranae Herba Sidae Szechuensis is thin for being ground into after first Mirabilitum crystallina, clean Mirabilitum and Radix Et Rhizoma Rhei being mixed
Face, then take Ha Noi and become the Tinea Ranae that lives end to end greatly to drag in closed cans, in Tinea Ranae closed cans of living after employing mudding tank mouth, then by mudding tank
The tank of mouth buries to earth 100-200 days, becomes Tinea Ranae water, then take Tinea Ranae water 100-200 after the Tinea Ranae alive in tank is melted into water
Milliliter is put in bowl, adds above-mentioned fine flour 50-100 gram and dry in the shade in bowl, then the solid abrasive after drying in the shade uniformly and becomes fine flour
Close in tank, be Tinea Ranae Herba Sidae Szechuensis;
Described SHENGJISAN, it makes active ingredient and is: Olibanum, Myrrha, each 1-2 gram of Margarita, catechu, Halloysitum Rubrum, Os Draconis, Corium elephatis,
Sanguis Draxonis 10-20 gram, 2-4 gram of mix homogeneously of Borneolum Syntheticum is processed into fine flour, is SHENGJISAN.
A kind of topical compositions medicament treating obstinate wound the most according to claim 1, it is characterised in that:
Described externally applied ointment, it makes active ingredient and is: 600-900 gram of Oleum Sesami, each 0.5-0.8 gram of Olibanum, Myrrha, Sanguis Draxonis,
Os Draconis (fire is forged) 1.5-2.5 gram, Flos Carthami, Radix Trichosanthis, Radix Angelicae Sinensis, each 0.7-0.9 gram of river Squama Manis, Crinis Carbonisatus 1.5-2.5 gram, Plumbum preparatium, take
After going out medicinal residues, oil and the weight ratio of Plumbum preparatium are 1 to compare 1.6-2.2;
Described Tinea Ranae Herba Sidae Szechuensis, it makes active ingredient and is: Mirabilitum crystallina 7-9 gram, clean Mirabilitum 5-7 gram, Radix Et Rhizoma Rhei 8-10 gram, lives
Tinea Ranae 700-1500 gram;
Described SHENGJISAN, it makes active ingredient and is: Olibanum, Myrrha, each 1.2-1.8 gram of Margarita, catechu, Halloysitum Rubrum, Os Draconis, as
Skin, Sanguis Draxonis 12-18 gram, Borneolum Syntheticum 2.5-3.5 gram.
A kind of topical compositions medicament treating obstinate wound the most according to claim 1 and 2, it is characterised in that:
Described externally applied ointment, it makes active ingredient and is: 800 grams of Oleum Sesami, each 0.7 gram of Olibanum, Myrrha, Sanguis Draxonis, Os Draconis (fire
Forge) 2 grams, each 0.8 gram of Flos Carthami, Radix Trichosanthis, Radix Angelicae Sinensis, river Squama Manis, Crinis Carbonisatus 2 grams, Plumbum preparatium, takes out the weight ratio of oil and Plumbum preparatium after medicinal residues
Be 1 to 2;
Described Tinea Ranae Herba Sidae Szechuensis, it makes active ingredient and is: Mirabilitum crystallina 8 grams, clean Mirabilitum 6 grams, Radix Et Rhizoma Rhei 9 grams, live Tinea Ranae
1000 grams;
Described SHENGJISAN, it makes active ingredient and is: Olibanum, Myrrha, each 1.5 grams of Margarita, catechu, Halloysitum Rubrum, Os Draconis, Corium elephatis,
Sanguis Draxonis 15 grams, Borneolum Syntheticum 3 grams.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610220643.6A CN105920276A (en) | 2016-04-12 | 2016-04-12 | Topical combined medicament for treating long-lasting wound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610220643.6A CN105920276A (en) | 2016-04-12 | 2016-04-12 | Topical combined medicament for treating long-lasting wound |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105920276A true CN105920276A (en) | 2016-09-07 |
Family
ID=56840154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610220643.6A Pending CN105920276A (en) | 2016-04-12 | 2016-04-12 | Topical combined medicament for treating long-lasting wound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105920276A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152388A (en) * | 2006-09-25 | 2008-04-02 | 黄朵 | Medicine for treating scald and burn, and method for preparing the same |
-
2016
- 2016-04-12 CN CN201610220643.6A patent/CN105920276A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152388A (en) * | 2006-09-25 | 2008-04-02 | 黄朵 | Medicine for treating scald and burn, and method for preparing the same |
Non-Patent Citations (2)
Title |
---|
孙世发主编: "《中华医方 外科篇 上》", 31 March 2015, 科学技术文献出版社 * |
谢观主编: "《中华医学大辞典》", 31 August 1994, 辽宁科学技术出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102920984B (en) | Medicine for curing rheumatoid arthritis | |
CN103961636B (en) | Orthopedic disease treatment external application traditional Chinese medicine composition, preparation method and application thereof | |
CN105920540A (en) | Oil capable of activating collaterals and preparation method thereof | |
CN108578465A (en) | A kind of Chinese medicine composition and its preparation method and application | |
CN110731953A (en) | Traditional Chinese medicine compound cataplasm for treating qi-stagnation and blood stasis type cervical spondylosis and preparation method thereof | |
CN107007714B (en) | A topical medicated liquor with effect in promoting callus formation | |
CN103070951B (en) | Externally used medicinal composition for treating cattle mange and preparation method thereof | |
CN102908524B (en) | External application Chinese medicine for treating burn and scald and use method thereof | |
CN105497534A (en) | Protection product for preventing and treating electric employee electric burn and fire burn | |
CN104474528A (en) | Medicine used for drainage detoxification | |
CN105920276A (en) | Topical combined medicament for treating long-lasting wound | |
CN103393894A (en) | Tinea relieving powder | |
CN1251753C (en) | Externally-applied medicine composition for treating mastoproliferation and its prepn | |
CN101940652B (en) | Chinese medicinal liniment for treating psoriasis, multiple kinds of stubborn dermatitis and pruritus | |
CN104825740A (en) | Traditional Chinese medicine composition for treating skin burn | |
CN105079206A (en) | Pain relieving traditional Chinese medicine composition and preparation method thereof | |
CN101564433B (en) | Chinese medicinal composition for treating rheumatic diseases, and preparation method thereof | |
CN103705761B (en) | Traditional Chinese medicine for treating cerebral hemorrhage diseases | |
CN104096027B (en) | It is a kind of to treat emplastrum of mastosis and preparation method thereof | |
CN104274540B (en) | Chinese medicine composition, preparation method and use containing tripterygium wilfordii | |
CN102697928B (en) | Preparation method for medicine composition for treating traumatic injury | |
CN107213238A (en) | It is a kind of to treat Chinese medicine of venomous snake bite and preparation method thereof | |
CN1927369A (en) | Medicine for curing burn and scald wound and its preparation method | |
CN110638951A (en) | Compound cataplasm for treating qi stagnation and blood stasis type lumbar intervertebral disc protrusion and preparation method thereof | |
CN1353998A (en) | Chinese medicine preparation for curing hemorrhoid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160907 |
|
RJ01 | Rejection of invention patent application after publication |